{"id":97766,"date":"2025-10-01T21:42:07","date_gmt":"2025-10-01T21:42:07","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/97766\/"},"modified":"2025-10-01T21:42:07","modified_gmt":"2025-10-01T21:42:07","slug":"european-shares-close-at-record-high-as-healthcare-outperforms-the-irish-times","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/97766\/","title":{"rendered":"European shares close at record high as healthcare outperforms \u2013 The Irish Times"},"content":{"rendered":"<p class=\"c-paragraph paywall \">Europe\u2019s Stoxx 600 closed at a record high on Wednesday, with healthcare stocks leading the way after a US-Pfizer deal reduced uncertainty in the sector, while investors digested the beginning of a US government shutdown.<\/p>\n<p class=\"c-paragraph paywall \">The pan-European Stoxx 600 surged 1.2 per cent to log its biggest one-day percentage gain since July 23rd. Most regional bourses were also trading higher, with London\u2019s FTSE 100 at a record high.<\/p>\n<p class=\"c-paragraph paywall \"><b>Dublin<\/b><\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\">Shares in nutrition group <b>Glanbia <\/b>dipped on Wednesday after its largest shareholder, Tirl\u00e1n Co-operative Society, sold a 6.8 per cent stake in the business. Tirl\u00e1n plans to use the \u20ac230 million proceeds from the share sale to help repurchase \u20ac250 million of bonds issued in 2022. Glanbia shares closed the session 2.2 per cent down at \u20ac13.70. <\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\"><b>AIB <\/b>and <b>Bank of Ireland <\/b>enjoyed a strong session with both stocks up 2 per cent. Dublin-listed home builders <b>Cairn <\/b>and <b>Glenveagh<\/b> were also up 1.9 per cent and 0.6 per cent respectively following good results in recent weeks.<\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\">Iseq heavyweight <b>Ryanair<\/b> fell marginally on the back of a general decline in leisure stocks.<\/p>\n<p class=\"c-paragraph paywall \"><b>Europe<\/b><\/p>\n<p class=\"c-paragraph paywall \">European healthcare stocks jumped 5.4 per cent, marking their biggest one-day performance since November 2008. On Tuesday, Pfizer agreed to lower prescription drug prices in the US Medicaid programme in exchange for tariff relief.<\/p>\n<p class=\"c-paragraph paywall \">\u201cThe sector generally has struggled over the last year or so and what we are hopefully beginning to see is some measure of clarity about what the rules of the game may look like,\u201d said Richard Flax, chief investment officer at Moneyfarm.<\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\">Other pharma stocks such as <b>Ambu<\/b> rose 9.3 per cent, <b>Sartorius<\/b> 9.5 per cent, <b>Merck<\/b> 10 per cent and <b>Roche<\/b> 8.6 per cent.<\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\"><b>Novartis<\/b> gained 3.9 per cent after the US Food and Drug Administration approved its oral treatment for a type of chronic inflammatory skin disease.<\/p>\n<p class=\"c-paragraph paywall \">All sectors were trading in the positive territory, but travel and leisure stocks bucked the trend with a 0.4 per cent dip.<\/p>\n<p class=\"c-paragraph paywall \"><b>London<\/b><\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\">London\u2019s FTSE 100 reached a fresh intraday peak on Wednesday, propelled by gains in the healthcare sector, with pharma giant <b>AstraZeneca<\/b> up 11 per cent alone, while investors assessed the ramifications of the US government shutdown on the release of critical economic indicators.<\/p>\n<p class=\"c-paragraph paywall \">The FTSE 100 index closed up 96.00 points, 1 per cent, at 9,446.43, beating its previous record close on Tuesday.<\/p>\n<p class=\"c-paragraph paywall \">The blue chip index had earlier set a new best level of 9,457.91 while the midcap index FTSE 250 fell 0.2 per cent.<\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\"><b>Tate &amp; Lyle<\/b> was the biggest drag on the index after the food ingredients maker warned that its annual profit and revenue would fall due to a demand slowdown in the Americas, its key market.<\/p>\n<p class=\"c-paragraph paywall \">Its shares plummeted 9.7 per cent to levels not seen since 2009.<\/p>\n<p class=\"c-paragraph paywall \">The aerospace and defence index was the biggest decliner among sectors, down 1.4 per cent, after gaining more than 2 per cent in the previous session.<\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\"> Among other stocks, <b>Greggs<\/b> rose 7.4 per cent after the bakery and fast-food chain reported a 6.1 per cent rise in third-quarter total sales, saying business improved in August and September. <\/p>\n<p class=\"c-paragraph paywall \"><b>New York<\/b><\/p>\n<p class=\"c-paragraph paywall \">The main US stock indexes declined on Wednesday as investors digested soft private payrolls data, while a federal government shutdown risked delaying economic data, heightening the uncertainty around the central bank\u2019s next policy move.<\/p>\n<p class=\"c-paragraph paywall \">Traders sharply increased bets on a 25-basis-point rate cut by the US. Federal Reserve at its next meeting after the ADP National Employment Report showed private payrolls dropped the most in two-and-a-half years in September.<\/p>\n<p class=\"c-paragraph paywall \">The labour market is walking a tightrope because data needs to be soft enough to support rate cuts, yet robust enough to avoid stoking fears of a broader economic slowdown.<\/p>\n<p class=\"c-paragraph paywall b-it-article-body__text--left\">Communication services shares on the S&amp;P 500 fell 1.5 per cent, dragged by losses in <b>Meta Platforms<\/b> and <b>Alphabet<\/b> , which shed 2.8 per cent and 1.1 per cent, respectively. The stocks also weighed on the Nasdaq. The S&amp;P 500 tech sector lost 0.4 per cent, with Nvidia down 0.9 per cent. &#8211; Additional reporting by Reuters<\/p>\n","protected":false},"excerpt":{"rendered":"Europe\u2019s Stoxx 600 closed at a record high on Wednesday, with healthcare stocks leading the way after a&hellip;\n","protected":false},"author":2,"featured_media":97767,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[5781,18,846,135,475,474,19,17,1997],"class_list":{"0":"post-97766","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-economic","9":"tag-eire","10":"tag-financial","11":"tag-health","12":"tag-health-care","13":"tag-healthcare","14":"tag-ie","15":"tag-ireland","16":"tag-trade"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/97766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=97766"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/97766\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/97767"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=97766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=97766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=97766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}